Search


	Podcast:		RCGP eLearning Podcast
	Episode:		COVID-19 Therapeutics
	Category:		Science & Medicine
	Duration:		00:17:10
	Publish Date:		2023-06-05 09:39:08
	Description:		We have come a long way from the start of the pandemic, when those well enough to avoid admission could not even access a COVID-19 test, let alone any specific therapeutics. Those in the highest-risk groups for severe consequences of COVID-19 can now access an antiviral or neutralising monoclonal antibody in the community. In this podcast, Dr Toni Hazell and Professor Simon de Lusignan outline the various drugs available, which are recommended by NICE, who is eligible for them and the practicalities of ensuring that your patients have access to these medications in a timely manner. They also discuss the PANORAMIC trial and which patients might want to take part in that, as well as the broader issues around testing for viruses in primary care. Full financial support for the design and development of this podcast is provided by Pfizer Ltd as a corporate sponsorship project, an arm’s length agreement. Pfizer has had no involvement in the content. Editorial and content decisions were made solely by the RCGP.
	Total Play:		0